Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan

BACKGROUND: Artesunate plus sulphadoxine-pyrimethamine (AS+SP) is now first-line treatment for Plasmodium falciparum infection in several south Asian countries, including Afghanistan. Molecular studies provide a sensitive means to investigate the current state of drug susceptibility to the SP compon...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Awab, Ghulam R, Pukrittayakamee, Sasithon, Jamornthanyawat, Natsuda, Yamin, Fazel, Dondorp, Arjen M, Day, Nicholas PJ, White, Nicholas J, Woodrow, Charles J, Imwong, Mallika
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2013
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3607912/
https://ncbi.nlm.nih.gov/pubmed/23497229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-12-96
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires